Germany’s Bayer considers diabetes device unit sale: report

Published: May 08, 2020

Wed May 9, 2020 10:44am IST

FRANKFURT (Reuters) - Germany’s largest drugmaker Bayer is considering the sale of its blood glucose meters business, a German newspaper reported.

Bayer has held talks with prospective buyers of its Diabetes Care unit, which has annual sales of about 1 billion euros ($1.3 billion), Financial Times Deutschland said in its Wednesday edition, citing sources close to the possible suitors and in the financial industry.

The paper said that Bayer declined to comment.

($1 = 0.7695 euros)

(Reporting by Ludwig Burger; Editing by Ed Lane)

Article source:

Tweet this

Published May 08, 2020 by in news
Tags: , ,

Leave a Reply